Company / Gross Margin
ENDRA Life Sciences Inc. Gross Margin History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
100.0%
FY2019
5-year range
50.9% / 100.0%
FY2017-FY2019
Trend
+96.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 50.9% to 100.0% over the past 2 years.
Based on SEC 10-K filings.
100.0% in FY2019.
Improved from 50.9% to 100.0% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, gross margin increased 96.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2019 | 100.0% | +96.6% |
| FY2018 | 50.9% | +0.0% |
| FY2017 | 50.9% | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026